Health Catalyst Statistics
Total Valuation
HCAT has a market cap or net worth of $464.27 million. The enterprise value is $424.91 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HCAT has 60.85 million shares outstanding. The number of shares has increased by 6.20% in one year.
Current Share Class | 60.85M |
Shares Outstanding | 60.85M |
Shares Change (YoY) | +6.20% |
Shares Change (QoQ) | +1.92% |
Owned by Insiders (%) | 2.76% |
Owned by Institutions (%) | 89.22% |
Float | 59.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 20.07 |
PS Ratio | 1.44 |
Forward PS | 1.32 |
PB Ratio | 1.26 |
P/TBV Ratio | 10.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.41 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.03.
Current Ratio | 1.41 |
Quick Ratio | 1.36 |
Debt / Equity | 1.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.53 |
Financial Efficiency
Return on equity (ROE) is -21.46% and return on invested capital (ROIC) is -5.94%.
Return on Equity (ROE) | -21.46% |
Return on Assets (ROA) | -5.26% |
Return on Capital (ROIC) | -5.94% |
Revenue Per Employee | $232,355 |
Profits Per Employee | -$60,878 |
Employee Count | 1,300 |
Asset Turnover | 0.40 |
Inventory Turnover | n/a |
Taxes
Income Tax | -149,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.52% in the last 52 weeks. The beta is 1.32, so HCAT's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -5.52% |
50-Day Moving Average | 8.15 |
200-Day Moving Average | 7.36 |
Relative Strength Index (RSI) | 40.10 |
Average Volume (20 Days) | 516,624 |
Short Selling Information
The latest short interest is 2.84 million, so 4.67% of the outstanding shares have been sold short.
Short Interest | 2.84M |
Short Previous Month | 2.61M |
Short % of Shares Out | 4.67% |
Short % of Float | 4.81% |
Short Ratio (days to cover) | 6.87 |
Income Statement
In the last 12 months, HCAT had revenue of $302.06 million and -$79.14 million in losses. Loss per share was -$1.34.
Revenue | 302.06M |
Gross Profit | 139.47M |
Operating Income | -64.25M |
Pretax Income | -86.06M |
Net Income | -79.14M |
EBITDA | -32.08M |
EBIT | -64.25M |
Loss Per Share | -$1.34 |
Full Income Statement Balance Sheet
The company has $387.26 million in cash and $364.33 million in debt, giving a net cash position of $22.92 million or $0.38 per share.
Cash & Cash Equivalents | 387.26M |
Total Debt | 364.33M |
Net Cash | 22.92M |
Net Cash Per Share | $0.38 |
Equity (Book Value) | 355.04M |
Book Value Per Share | 5.83 |
Working Capital | 133.63M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$955,000 and capital expenditures -$1.46 million, giving a free cash flow of -$2.41 million.
Operating Cash Flow | -955,000 |
Capital Expenditures | -1.46M |
Free Cash Flow | -2.41M |
FCF Per Share | -$0.04 |
Full Cash Flow Statement Margins
Gross margin is 46.17%, with operating and profit margins of -21.27% and -26.20%.
Gross Margin | 46.17% |
Operating Margin | -21.27% |
Pretax Margin | -26.25% |
Profit Margin | -26.20% |
EBITDA Margin | -10.62% |
EBIT Margin | -21.27% |
FCF Margin | -5.60% |
Dividends & Yields
HCAT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.20% |
Shareholder Yield | -6.20% |
Earnings Yield | -17.67% |
FCF Yield | -0.54% |
Analyst Forecast
The average price target for HCAT is $11.65, which is 50.07% higher than the current price. The consensus rating is "Buy".
Price Target | $11.65 |
Price Target Difference | 50.07% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HCAT has an Altman Z-Score of -1.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.11 |
Piotroski F-Score | 3 |